These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8772676)

  • 21. [Pharmacological treatment of heart failure].
    Held P; Rosenqvist M; Rydén L; Swedberg K
    Lakartidningen; 1992 Aug; 89(35):2755-8. PubMed ID: 1405866
    [No Abstract]   [Full Text] [Related]  

  • 22. Afterload reduction in the management of congestive heart failure following acute myocardial infarction.
    Miller RR; Awan NA; Mason DT
    Adv Cardiol; 1978; 23():173-81. PubMed ID: 345758
    [No Abstract]   [Full Text] [Related]  

  • 23. [Peripheral vasodilator agents in cardiology].
    Khomenko VL; Pomerantsev VP; Vasiuk IuA
    Sov Med; 1980; (12):70-5. PubMed ID: 6784251
    [No Abstract]   [Full Text] [Related]  

  • 24. Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure.
    Steimle AE; Stevenson LW; Chelimsky-Fallick C; Fonarow GC; Hamilton MA; Moriguchi JD; Kartashov A; Tillisch JH
    Circulation; 1997 Aug; 96(4):1165-72. PubMed ID: 9286945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasodilator therapy for chronic congestive heart failure.
    Abrams J
    JAMA; 1985 Dec; 254(21):3070-4. PubMed ID: 3932697
    [No Abstract]   [Full Text] [Related]  

  • 26. Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure. Acute effects of the endothelin receptor antagonist Ro 47-0203 (bosentan).
    Teerlink JR; Löffler BM; Hess P; Maire JP; Clozel M; Clozel JP
    Circulation; 1994 Nov; 90(5):2510-8. PubMed ID: 7955209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Vasodilator therapy in cardiac failure].
    Akatsuka N
    Nihon Rinsho; 1993 May; 51(5):1276-80. PubMed ID: 8101237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of sequential big endothelin plasma concentrations to predict rapid worsening of chronic heart failure.
    Stanek B; Frey B; Berger R; Hartter E; Pacher R
    Transplant Proc; 1999; 31(1-2):155-7. PubMed ID: 10083055
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pharmacologic interactions with nitrates in patients with, or at risk of, cardiac decompensation].
    Filardi PP; Chiariello M
    G Ital Cardiol; 1996 Sep; 26(9):1085-8. PubMed ID: 9036050
    [No Abstract]   [Full Text] [Related]  

  • 30. Rationalizing the heart failure trials: from theory to practice.
    Struthers AD
    Eur Heart J; 1997 Nov; 18 Suppl E():E5-8. PubMed ID: 9402465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vasodilator therapy in chronic congestive heart failure.
    Schwartz AB; Chatterjee K
    Drugs; 1983 Aug; 26(2):148-73. PubMed ID: 6349967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelin antagonists for chronic heart failure: do they have a role?
    Cowburn PJ; Cleland JG
    Eur Heart J; 2001 Oct; 22(19):1772-84. PubMed ID: 11549299
    [No Abstract]   [Full Text] [Related]  

  • 33. The cardiomyopathy of overload: an unnatural growth response.
    Katz AM
    Eur Heart J; 1995 Dec; 16 Suppl O():110-4. PubMed ID: 8682075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of the cardiac endothelin system in heart failure.
    Zolk O; Böhm M
    Nephrol Dial Transplant; 2000 Jun; 15(6):758-60. PubMed ID: 10831623
    [No Abstract]   [Full Text] [Related]  

  • 35. [Heart failure, summary and perspectives].
    Just H
    Z Kardiol; 1992; 81 Suppl 4():105-8. PubMed ID: 1290286
    [No Abstract]   [Full Text] [Related]  

  • 36. [The role of nitrates in therapy of heart failure].
    Strasser RH
    Herz; 1996 Jun; 21 Suppl 1():35-7. PubMed ID: 8767923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vasodilator therapy for congestive heart failure. Lessons from mortality trials.
    Groden DL
    Arch Intern Med; 1993 Feb; 153(4):445-54. PubMed ID: 8435024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of heart failure: what--when--how?].
    Blömer H
    Verh Dtsch Ges Inn Med; 1990; 96():157-67. PubMed ID: 2092435
    [No Abstract]   [Full Text] [Related]  

  • 39. Vasodilator therapy without converting-enzyme inhibition in congestive heart failure--usefulness and limitations.
    Remme WJ
    Cardiovasc Drugs Ther; 1989 Jun; 3(3):375-96. PubMed ID: 2487535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of chronic heart failure.
    Packer M
    Lancet; 1992 Jul; 340(8811):92-5. PubMed ID: 1352023
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.